Northwestern Faculty Discuss Startups in Farley Fellows Lecture Series
Chad Mirkin and Milan Mrksich to discuss entrepreneurship in November 12 lecture
Research and entrepreneurship go hand in hand, but commercializing technology requires a vastly different skill set than creating it. In the new Farley Fellows Seminar Series, Northwestern faculty members who have succeeded as entrepreneurs will discuss lessons they have learned in areas such as product development, financing, market investigation, pivoting, and building a business team.
Farley Fellows are entrepreneurship-minded faculty members who advise Northwestern’s Farley Center for Entrepreneurship and Innovation, mentor students and other faculty, and lead by example. All fellows have companies or are involved in substantial entrepreneurial efforts.
The Farley Fellows lectures will be held in the Ford Motor Company Engineering Design Center ITW classroom, 2133 Sheridan Road, on Northwestern’s Evanston campus. Graduate students, postdoctoral researchers, and faculty are especially encouraged to attend.
Tuesday, November 12, 2:30 p.m
Chad Mirkin, George B. Rathmann Professor of Chemistry, Materials Science and Engineering, and (by courtesy) Chemical and Biological Engineering and Biomedical Engineering
A world-renowned leader in nanotechnology, Mirkin invented spherical nucleic acids (SNAs), new globular forms of DNA and RNA that now form the basis for more than 300 products commercialized by licensees of the technology. Mirkin himself has launched four companies: Nanosphere, a developer of the Verigene System, an advanced molecular diagnostic platform; NanoInk, a nanotechnology company providing a platform process for nano-scale fabrication; and AuraSense and AuraSense Therapeutics, which explore and commercialize his SNA constructs.
Milan Mrksich, Henry Wade Rogers Professor of Biomedical Engineering, Chemistry, and Cell and Molecular Biology
Mrksich’s research combines synthetic chemistry with materials science to study important problems in cell biology. He is a co-founder of Arsenal Medical Inc., a medical devices company that has a stent product in clinical trials, and more recently co-founded SAMDI Tech, an early-stage technology company based on his new platform for analyzing biochemical reactions. Technology Review magazine named Mrksich as a "100 Top Young Innovators" in 2002.